IP Verse

Thorne Research, Inc. v. Niagen Biosciences, Inc. - 2:26-cv-01758

Thorne Research, Inc. v. Niagen Biosciences, Inc. (Case No. 2:26-cv-01758), filed on Apr 28, 2026 in the District Court, D. South Carolina involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
2:26-cv-01758
Filing Date
Apr 28, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. South Carolina
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Thorne Research, Inc. -
Chromadex, Inc. -
The Queen's University of Belfast -
Niagen Biosciences, Inc. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US12252506B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)PACER Document
Apr 29, 2026Local Rule 26.01 Answers to Interrogatories by Thorne Healthtech, Inc., Thorne Research, Inc..(hcor, ) (Entered: 04/29/2026)PACER Document
Apr 29, 2026Summons Issued as to Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast. (hcor, ) (Entered: 04/29/2026)PACER Document
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment
Apr 29, 2026COMPLAINT against Chromadex, Inc., Niagen Biosciences, Inc., The Queen's University of Belfast ( Filing fee $ 405 receipt number ASCDC-13139362.), filed by Thorne Research, Inc., Thorne Healthtech, Inc.. Service due by 7/27/2026 (Attachments: # 1 Exhibit 1 - US 12,252,506, # 2 Exhibit 2 - Patent Assignment, # 3 Exhibit 3 - APEX Agreement, # 4 Exhibit 4 - Niagen PR, # 5 Exhibit 5 - Niagen 10-K [EXCERPT], # 6 Exhibit 6 - APEX Procedure, # 7 Exhibit 7 - 4.10.26 Email, # 8 Exhibit 8 - Account health rating, # 9 Exhibit 9 - What is Amazon Account Health)(hcor, ) (Entered: 04/29/2026)Attachment